Patient Pathfinder: Clinical Trials
Clinical Trials for Bladder Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 279 active Bladder Cancer trials
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
Study Type: Interventional Phase 3
MK-3475/BCG in High Risk Superficial Bladder Cancer
Study Type: Interventional Phase 1
Molecular Biosensors for Detection of Bladder Cancer
Study Type: Observational
Biomarker Identification for Bladder Cancer Patients
Study Type: Observational
Evaluation of the PhageTech Virus BioResistor
Study Type: Observational
Durvalumab And Radiation Therapy Followed by Adjuvant Durvalumab in Patients With Urothelial Cancer (T2-4 N0-2 M0) of the Bladder
Study Type: Interventional Phase 1
Clinical Evaluation of the miR Sentinel BCa™ Test to Diagnose Bladder Cancer in Hematuria Patients
Study Type: Observational
There are 279 active Bladder Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now